Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Migraine Disorders: HELP
Andrew C. Charles
Based on 34 articles published since 2007
||||
Expertise Level
The expertise of Andrew C. Charles ranks in the
  • Top 0.064%
  • ... of 22,045 published authors worldwide on Migraine Disorders
  • ... from 2007 through 2018
  • ... based on contributions to 34 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Charles, Andrew C   ·   Charles, Andrew
Work Locations
Details
Most likely:    UCLA   Contact    
2017
  • From the UCLA Goldberg Migraine Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles. · Pubmed 28792865
  • David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: · David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Jefferson Headache Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. · Intermountain Medical Center, Salt Lake City, Utah. · Tenet Healthcare Corporation, Boca Raton, Florida. · University of Iowa Carver College of Medicine, Iowa City, Iowa. · University of Kentucky College of Medicine, Lexington, Kentucky. · Pubmed 29191325
  • Stein Eye Institute, University of California, Los Angeles, California, United States. · Doheny Eye Institute, University of California, Los Angeles, California, United States. · Department of Ophthalmology, University of California, Los Angeles, California, United States. · Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. · Department of Neurology, University of California, Los Angeles, California, United States. · Pubmed 29059314
  • UCLA Goldberg Migraine Program, Los Angeles, CA · Pubmed 29069565
2016
  • Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine, UCLALos Angeles, CA, USA; Brain Research Institute, UCLALos Angeles, CA, USA. · Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA Los Angeles, CA, USA. · Department of Neurobiology and Medicine, David Geffen School of Medicine, UCLA Los Angeles, CA, USA. · Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University Lund, Sweden. · Brain Research Institute, UCLALos Angeles, CA, USA; Department of Neurology, David Geffen School of Medicine, UCLALos Angeles, CA, USA. · Department of Neurobiology and Medicine, David Geffen School of Medicine, UCLALos Angeles, CA, USA; Departments of Physiology & Biophysics and Ophthalmology and Visual Sciences, Dalhousie UniversityHalifax, NS, Canada. · Brain Research Institute, UCLALos Angeles, CA, USA; Department of Neurobiology and Medicine, David Geffen School of Medicine, UCLALos Angeles, CA, USA; Veterans Administration Greater Los Angeles Health SystemLos Angeles, CA, USA. · Pubmed 27559310
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
  • From the David Geffen School of Medicine, UCLA, Los Angeles, CA. · Pubmed 26843565
  • 1 Department of Psychiatry, University of Illinois at Chicago, USA. · 2 Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, UCLA, USA. · Pubmed 26682574
  • Headache Research and Treatment Program, Department of Neurology, University of California Los Angeles, USA · Headache Group, Clinical Neurosciences and NIHR-Wellcome Trust Clinical Research Facility, King's College London, UK. · Headache Research and Treatment Program, Department of Neurology, University of California Los Angeles, USA. · Pubmed 25944814
2015
  • Headache Research and Treatment Program, Department of Neurology, UCLA School of Medicine, USA · Pubmed 25616609
  • Department of Neurology and Headache Center, University of Duisburg-Essen, Essen, Germany. Electronic address: · Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, UK. · Department of Neurology and Headache Center, University of Duisburg-Essen, Essen, Germany. · Pubmed 26376968
  • aHeadache Research and Treatment Program, Department of Neurology, University of California Los Angeles, California, USA bDanish Headache Centre and Department of Neurology, Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Pubmed 25923125
2014
  • Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA; Department of Psychiatry, University of Illinois at Chicago, USA. Electronic address: · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA. · Pubmed 24121068
2013
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Neuroscience Research Building 1, Room 575, 635 Charles Young Drive South, Los Angeles, CA 90095-7335, USA. · Pubmed 24042483
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. · Pubmed 23493160
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 23278169
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. · Pubmed 23578774
2012
  • Department of Neurology, UCLA School of Medicine. · Pubmed 23196458
  • David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. · Pubmed 22523235
2010
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Pubmed 20456161
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. · Pubmed 20816413
2009
  • Department of Neurology, David Geffen School of Medicine at University of California-Los Angeles, 635 Charles Young Drive, Los Angeles, CA 90095, USA. · Pubmed 19479724
2007
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, 635 Charles Young Drive, Suite 575, Los Angeles, CA 90095, USA. · Pubmed 17901918
2015
  • From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · Pubmed 25841032
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
2013
  • 1 Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Pubmed 24264937
  • Department of Neurology, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 23636092
  • Department of Neurology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA. · Pubmed 23424170
2010
  • Department of Neurology, David Geffen School of Medicine at UCLA, California, USA. · Pubmed 20216215
2007
  • Department of Neurology, University of California, Los Angeles, CA 90095, USA. · Pubmed 17474110
Probable:    University of Illinois Chicago   Contact    
2016
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
Probable:    Copenhagen University Hospital      
2015
  • aHeadache Research and Treatment Program, Department of Neurology, University of California Los Angeles, California, USA bDanish Headache Centre and Department of Neurology, Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Pubmed 25923125
2015
  • From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · Pubmed 25841032
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 34 total) written by Andrew C. Charles about Migraine Disorders:

  • Migraine. 2017
  • Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial. 2017
  • Foveal and Peripapillary Vascular Decrement in Migraine With Aura Demonstrated by Optical Coherence Tomography Angiography. 2017
  • Migraine. 2017
  • Peripheral Sensory Neurons Expressing Melanopsin Respond to Light. 2016
  • Delta-opioid receptors as targets for migraine therapy. 2016
  • Comment: Outcomes of migraine therapy with IV dihydroergotamine. 2016
  • The effects of acute and preventive migraine therapies in a mouse model of chronic migraine. 2016
  • Variability of clinical features in attacks of migraine with aura. 2016
  • Sounding out migraine-related interactions between the brainstem and cortex. 2015
Show List of Full Article Records
Google Searches

Learn more about Andrew C. Charles using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
UCLA
University of Illinois Chicago
Copenhagen University Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
UCLA
2017
  • From the UCLA Goldberg Migraine Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles. · Pubmed 28792865
  • David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: · David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Jefferson Headache Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. · Intermountain Medical Center, Salt Lake City, Utah. · Tenet Healthcare Corporation, Boca Raton, Florida. · University of Iowa Carver College of Medicine, Iowa City, Iowa. · University of Kentucky College of Medicine, Lexington, Kentucky. · Pubmed 29191325
  • Stein Eye Institute, University of California, Los Angeles, California, United States. · Doheny Eye Institute, University of California, Los Angeles, California, United States. · Department of Ophthalmology, University of California, Los Angeles, California, United States. · Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. · Department of Neurology, University of California, Los Angeles, California, United States. · Pubmed 29059314
  • UCLA Goldberg Migraine Program, Los Angeles, CA · Pubmed 29069565
2016
  • Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine, UCLALos Angeles, CA, USA; Brain Research Institute, UCLALos Angeles, CA, USA. · Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA Los Angeles, CA, USA. · Department of Neurobiology and Medicine, David Geffen School of Medicine, UCLA Los Angeles, CA, USA. · Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University Lund, Sweden. · Brain Research Institute, UCLALos Angeles, CA, USA; Department of Neurology, David Geffen School of Medicine, UCLALos Angeles, CA, USA. · Department of Neurobiology and Medicine, David Geffen School of Medicine, UCLALos Angeles, CA, USA; Departments of Physiology & Biophysics and Ophthalmology and Visual Sciences, Dalhousie UniversityHalifax, NS, Canada. · Brain Research Institute, UCLALos Angeles, CA, USA; Department of Neurobiology and Medicine, David Geffen School of Medicine, UCLALos Angeles, CA, USA; Veterans Administration Greater Los Angeles Health SystemLos Angeles, CA, USA. · Pubmed 27559310
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
  • From the David Geffen School of Medicine, UCLA, Los Angeles, CA. · Pubmed 26843565
  • 1 Department of Psychiatry, University of Illinois at Chicago, USA. · 2 Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, UCLA, USA. · Pubmed 26682574
  • Headache Research and Treatment Program, Department of Neurology, University of California Los Angeles, USA · Headache Group, Clinical Neurosciences and NIHR-Wellcome Trust Clinical Research Facility, King's College London, UK. · Headache Research and Treatment Program, Department of Neurology, University of California Los Angeles, USA. · Pubmed 25944814
2015
  • Headache Research and Treatment Program, Department of Neurology, UCLA School of Medicine, USA · Pubmed 25616609
  • Department of Neurology and Headache Center, University of Duisburg-Essen, Essen, Germany. Electronic address: · Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, UK. · Department of Neurology and Headache Center, University of Duisburg-Essen, Essen, Germany. · Pubmed 26376968
  • aHeadache Research and Treatment Program, Department of Neurology, University of California Los Angeles, California, USA bDanish Headache Centre and Department of Neurology, Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Pubmed 25923125
2014
  • Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA; Department of Psychiatry, University of Illinois at Chicago, USA. Electronic address: · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA. · Pubmed 24121068
2013
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Neuroscience Research Building 1, Room 575, 635 Charles Young Drive South, Los Angeles, CA 90095-7335, USA. · Pubmed 24042483
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. · Pubmed 23493160
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 23278169
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. · Pubmed 23578774
2012
  • Department of Neurology, UCLA School of Medicine. · Pubmed 23196458
  • David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. · Pubmed 22523235
2010
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Pubmed 20456161
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. · Pubmed 20816413
2009
  • Department of Neurology, David Geffen School of Medicine at University of California-Los Angeles, 635 Charles Young Drive, Los Angeles, CA 90095, USA. · Pubmed 19479724
2007
  • Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, 635 Charles Young Drive, Suite 575, Los Angeles, CA 90095, USA. · Pubmed 17901918
2015
  • From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · Pubmed 25841032
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
2013
  • 1 Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Pubmed 24264937
  • Department of Neurology, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 23636092
  • Department of Neurology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA. · Pubmed 23424170
2010
  • Department of Neurology, David Geffen School of Medicine at UCLA, California, USA. · Pubmed 20216215
2007
  • Department of Neurology, University of California, Los Angeles, CA 90095, USA. · Pubmed 17474110
University of Illinois Chicago
2016
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
Copenhagen University Hospital
2015
  • aHeadache Research and Treatment Program, Department of Neurology, University of California Los Angeles, California, USA bDanish Headache Centre and Department of Neurology, Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Pubmed 25923125
2015
  • From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR-Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · Pubmed 25841032
5 Other Locations Show
Yearly article counts 045427304122
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.